SPI-1005 for the Treatment of Patients With Meniere's Disease
Public ClinicalTrials.gov record NCT03325790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Safety And Efficacy of SPI-1005 in Meniere's Disease
Study identification
- NCT ID
- NCT03325790
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sound Pharmaceuticals, Incorporated
- Industry
- Enrollment
- 149 participants
Conditions and interventions
Conditions
Interventions
- 200mg SPI-1005 BID Drug
- 400mg SPI-1005 BID Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 27, 2017
- Primary completion
- Apr 29, 2019
- Completion
- Apr 29, 2019
- Last update posted
- Sep 17, 2023
2017 – 2019
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ccent/Cccr | Fresno | California | 93720 | — |
| UCSD | San Diego | California | 92093 | — |
| UCSF | San Francisco | California | 94115 | — |
| Georgetown University | Washington D.C. | District of Columbia | 20057 | — |
| UMiami | Miami | Florida | 33146 | — |
| KUMC | Kansas City | Kansas | 66160 | — |
| Advanced ENT & Allergy | Louisville | Kentucky | 40207 | — |
| ENT and Allergy Associates, LLP | New York | New York | 10017 | — |
| CEENTA | Charlotte | North Carolina | 28210 | — |
| TJU | Philadelphia | Pennsylvania | 19144 | — |
| MUSC | Charleston | South Carolina | 29425 | — |
| UT Southwestern | Dallas | Texas | 75390 | — |
| Northwest Ear, Inc. | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03325790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 17, 2023 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03325790 live on ClinicalTrials.gov.